Europe — EMA

Ovastat (Treosulfan)

Treosulfan, the active ingredient in Ovastat, is a alkylating agent presented as a sterile lyophilized powder for intravenous infusion use.

Treosulfan

Request sourcing

Pack/s

What is Treosulfan?

Treosulfan, the active ingredient in Ovastat, is a alkylating agent presented as a sterile lyophilized powder for intravenous infusion use. It is employed in conditioning regimens for hematopoietic stem cell transplantation in adult and adult patients. GNH USA supplies Ovastat as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and oncology centres worldwide.

GNH USA supplies Ovastat as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and oncology centres worldwide.

What is Treosulfan used for?

Ovastat is an alkylating agent that is used in conditioning regimens for hematopoietic stem cell transplantation.

- Allogeneic stem cell transplantation: Provides the pre‑transplant myeloabl my my my my my my. - Autologous ... - - - -

What are the side effects of Treosulfan?

Common

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →